Clinical Trial

Investigating a Brief Virtual Seminar Series for Parents of Children Ages 2-12

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated July 14, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to determine whether a brief positive parenting seminar series delivered virtually helps teach parents additional tools and strategies to support healthy child development, encourage good behavior, and manage misbehavior, while improving parenting practices and child outcomes for parents of children ages 2-12. The main questions it aims to answer are whether parents are satisfied with the intervention and find the strategies helpful and acceptable, whether the intervention leads to changes in parenting behaviors (e.g., positive parenting) and child outcomes (e.g., emotional and behavioral problems), and how removing the active discussion from the seminars impacts parents' ability to improve their parenting skills and their child's outcomes. Researchers will compare three groups: parents receiving the seminars with a group discussion, parents receiving the seminars without a group discussion, and parents on a waitlist. This will help determine if group discussions lead to greater improvements in parenting practices and child outcomes. Participants attended three online parenting seminars via telehealth (if assigned to a seminar group). They completed surveys before, during, and after the seminars to share their experiences and provide feedback. Participants in the waitlist group completed surveys at the beginning and end of the study, and will participate in the seminars after the study period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-03.
Status change: Completed → Active, Not Recruiting 2026-03-26
Trial Details
NCT Number NCT06865183
Lead Sponsor Texas Tech University
Conditions Positive Parenting Skills
Enrollment 123 participants
Start Date 2024-02-23
Primary Completion 2026-07-14 (estimated)
Study Completion 2026-07-14 (estimated)
Updated on ClinicalTrials.gov 2026-03-27